about
MicroRNA and signal transduction pathways in tumor radiation responseAberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p.Identification and characterization of microRNAs in Baylisascaris schroederi of the giant pandaIncreased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinomaOxidative stress in apoptosis and cancer: an update.MicroRNAs in osteosarcoma: from biological players to clinical contributors, a review.SMMRNA: a database of small molecule modulators of RNA.The diagnosis, prognosis, and therapeutic application of MicroRNAs in haematological malignancies.Roles for long non-coding RNAs in physiology and disease.MicroRNA-874 inhibits cell proliferation and induces apoptosis in human breast cancer by targeting CDK9.miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease.Preliminary evaluation of circulating microRNAs as potential biomarkers in paracoccidioidomycosis.Nano-based delivery of RNAi in cancer therapy.High serum microRNA-335 level predicts aggressive tumor progression and unfavorable prognosis in pediatric acute myeloid leukemia.Upregulation of microRNA-375 is associated with poor prognosis in pediatric acute myeloid leukemia.The expression of Mirc1/Mir17-92 cluster in sputum samples correlates with pulmonary exacerbations in cystic fibrosis patients.Nanotechnology based approaches for detection and delivery of microRNA in healthcare and crop protection.MicroRNA-129-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting DNMT3A
P2860
Q27027546-2433B35F-23BB-46E6-8427-DAEACE884568Q36074982-597C52D0-3848-4E3B-90AF-15FF400A0453Q37053357-F595ED64-5C8B-4702-AA2C-0AAE64E160F9Q37313015-32620369-9158-4E32-B5B1-2FF311B75ECFQ38027434-F1633CFD-656E-4CE0-ABF2-BFF47EDB4675Q38097415-68E3057E-979C-422F-9CB1-F4B4CA9D4279Q38491740-5D240692-244D-4A11-85B4-7FE3CFCC84AFQ38747300-E052B824-317B-4139-AF7E-CE51EE9A70D4Q38761159-D43A4E03-4F0B-4D3C-9A53-9EEF78E1B033Q38950635-3630CDD2-11B4-44E8-BD68-5C36377B2E67Q39223387-3AB13ABE-A9EC-44A8-9F7E-B41A67A9D9DFQ40234466-DA829D07-7551-4BA0-A236-376385A199DFQ42339315-CBBFA2E6-49DF-4336-B366-773F6D9D28C2Q44001281-445701BE-222B-4492-8A21-69D09FC5DFDFQ46679788-01217607-C5B6-4193-9BD7-516E539615E2Q47680467-2410E61F-5B39-4941-A3B1-320C1AB60B33Q52589516-AB043AAC-7B63-43C5-BAF0-EB558F95ADC3Q57493383-64FDAE36-2630-4B00-B7B2-C0242B89F48D
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
MicroRNA as a novel drug target for cancer therapy.
@en
MicroRNA as a novel drug target for cancer therapy.
@nl
type
label
MicroRNA as a novel drug target for cancer therapy.
@en
MicroRNA as a novel drug target for cancer therapy.
@nl
prefLabel
MicroRNA as a novel drug target for cancer therapy.
@en
MicroRNA as a novel drug target for cancer therapy.
@nl
P2093
P2860
P1476
MicroRNA as a novel drug target for cancer therapy.
@en
P2093
P2860
P304
P356
10.1517/14712598.2012.671293
P407
P577
2012-03-20T00:00:00Z